Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
amlodipine besilate, Quantity: 6.935 mg; olmesartan medoxomil, Quantity: 20 mg
Arrotex Pharmaceuticals Pty Ltd
amlodipine besilate,Olmesartan medoxomil
Tablet
Excipient Ingredients: magnesium stearate; powdered cellulose; purified talc; titanium dioxide; microcrystalline cellulose; polyvinyl alcohol; macrogol 8000; silicon dioxide; croscarmellose sodium
Oral
30, 1000
(S4) Prescription Only Medicine
Olmesartan and amlodipine combination tablets are indicated for the treatment of hypertension. Treatment should not be initiated with this fixed-dose combination (see Dosage and administration).
Visual Identification: White coloured, round shaped, biconvex, film coated tablets with "APO" engraved on one side and "20 over 5" on the other side.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 24 Months; Container Temperature: Store below 30 degrees Celsius
Licence status A
2016-01-12